Revisi per 21 April 2009 01.19 sunting SkullSplitter (bicara \| kontrib) 5.138 suntingan Tidak ada ringkasan suntingan ← Revisi sebelumnya		Revisi per 13 Mei 2009 19.14 sunting balikkan Borgxbot (bicara \| kontrib) 259.487 suntingan k Robot: Cosmetic changes Revisi selanjutnya →
Baris 6: foundation = [[20 Agustus]] [[2004]] ''oleh merger'' \| location = [[Paris]], [[Perancis]]\| key_people = [[Jean-François Dehecq]] ''Chairman''<{{br/>}}[[Gérard Le Fur]] ''CEO''\| industry = [[Farmasi]]\| num_employees = 96,439 (2004) \| products = [[Cardiovascular]], [[central nervous system]], [[oncology]], dan [[internal medicine]] formulations.<{{br />}}Flagship products:<{{br />}}[[Fexofenadine\|Allegra®]] (allergy)<{{br />}}[[Enoxaparin\|Lovenox®]] (deep vein thrombosis)<{{br />}}[[Clopidogrel\|Plavix®]] (thrombosis)<{{br />}}[[Irbesartan\|Avapro®]] (hypertension)<{{br />}}[[Zolpidem\|Ambien®]] (insomnia)<{{br />}}[[Oxaliplatin\|Eloxatin®]] (chemotherapy) <{{br />}} [[Telithromycin\|Ketek®]] ([[ketolide]] [[antibiotic]])\| revenue = [[Berkas:green up.png]]27.311 miliar [[euro]]s ([[2005]])<{{br />}}   ($34.013 billion [[Dolar Amerika Serikat\|USD]])\| homepage = [http://en.sanofi-aventis.com/ en.sanofi-aventis.com]\| }}

Sanofi: Perbedaan antara revisi